Oxford BioMedica (OTCMKTS:OXBDF) Shares Gap Down – What’s Next?

Shares of Oxford BioMedica (OTCMKTS:OXBDF) gapped down prior to trading on Thursday . The stock had previously closed at $7.34, but opened at $6.9744. Oxford BioMedica shares last traded at $6.9744, with a volume of 800 shares.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised shares of Oxford BioMedica to a “hold” rating in a research note on Wednesday, July 22nd. One analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the stock currently has an average rating of “Hold”.

Oxford BioMedica Price Performance

The stock’s 50 day simple moving average is $7.76 and its 200-day simple moving average is $8.38.

Oxford BioMedica Company Profile

Oxford BioMedica is a clinical-stage gene and cell therapy company headquartered in Oxford, United Kingdom. The company specializes in the development, manufacturing and commercialization of lentiviral vector delivery systems for use in treating serious diseases. Its proprietary LentiVector® platform underpins both in-house development programs and third-party collaborations, enabling the stable integration of therapeutic genes into target cells.

In its research pipeline, Oxford BioMedica is advancing candidates across ophthalmology, neuroscience and oncology indications.